We have collected information about Current And Future Ophthalmic Drug Delivery Systems for you. Follow the links to find out details on Current And Future Ophthalmic Drug Delivery Systems.
https://www.ncbi.nlm.nih.gov/pubmed/18275911
Effective, safe, and comfortable methods of drug delivery are needed. The emerging methods include polymeric-controlled release injections and implants, nanoparticulates, microencapsulated cells, iontophoresis, and gene medicines.Author: Eva M. del Amo, Arto Urtti
https://www.sciencedirect.com/science/article/pii/S1359644607004916
Nowadays, there are, on the market or undergoing clinical trials, ocular drug delivery systems designed to sustain drug release. Most of them are for the treatment of long-term diseases that affect the posterior segment of the eye . The important indications for ocular drug delivery systems include macular degeneration, viral infections (like CMV infections), glaucoma, ocular inflammations, dry eye syndrome, and retinal degenerations.Author: Eva M. del Amo, Arto Urtti
https://www.ondrugdelivery.com/current-future-ophthalmic-formulation-process-development-trends/
Now, approximately 14 years later, ophthalmic drug delivery continues to transcend with various trends in the pharmaceutical industry. Companies are targeting their drug delivery systems and molecules toward glaucoma, retinal disorders, dry-eye treatments and as …
https://www.semanticscholar.org/paper/Current-and-future-ophthalmic-drug-delivery-A-shift-Amo-Urtti/bba7b8c8b8cebd1818412da1522ee0ff7451215f
Medicine; Published in Drug discovery today 2008; DOI: 10.1016/j.drudis.2007.11.002 Current and future ophthalmic drug delivery systems. A shift to the posterior segment. @article{Amo2008CurrentAF, title={Current and future ophthalmic drug delivery systems.
https://www.researchgate.net/publication/5575929_Current_and_future_ophthalmic_drug_delivery_systems_A_shift_to_the_posterior_segment
Current and future ophthalmic drug delivery systems. A shift to the posterior segment Article · Literature Review in Drug Discovery Today 13(3-4):135-43 · March 2008 with 1,168 Reads
http://jpet.aspetjournals.org/content/early/2019/05/09/jpet.119.256933
Jan 01, 2019 · An ideal drug delivery system should be designed to enhance drug bioavailability, provide controlled and sustained release of drug at site of action and overcome various ocular barriers. Conventional ophthalmic medications includes the use of topical eye drops and intravitreal injections of anti-VEGF agent for treatment of anterior and posterior segment disorders respectively.Author: Vrinda Gote, Sadia Sikder, Jeff Sicotte, Dhananjay Pal
Searching for Current And Future Ophthalmic Drug Delivery Systems?
You can just click the links above. The data is collected for you.
